Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor-associated antigen peptide (HLA-A*02 restricted)
- Molecular classification
- Peptide, Antigen
01
Overview
Tumor-associated antigen peptides presented by HLA-A*02:01 are short peptides derived from tumor proteins. These peptides are presented on the surface of cancer cells, enabling recognition by cytotoxic T lymphocytes, making them prime targets for cancer immunotherapies. Their restricted presentation via HLA-A*02:01 and their origin from overexpressed/uniquely expressed tumor proteins provide specificity against cancer cells.
- Other names
- HLA-A*02:01 restricted tumor antigenTumor-specific peptide presented by HLA-A2HLA-A2 restricted TAA peptide
02
Mechanism of action
Presentation by HLA-A*02:01 allows recognition by cytotoxic CD8+ T lymphocytes, leading to tumor cell lysis.
03
Biological functions
Antigen presentationT cell activationImmune recognitionTumor cell targeting
04
Disease associations
CancerImmune evasion
05
Safety considerations
On-target, off-tumor toxicityCytokine release syndromeAutoimmunity
06
Interacting drugs
Peptide vaccines
2 more in the full profile.
07
Biomarkers
HLA-A*02:01 statusExpression level of the source tumor antigenT cell reactivity against the peptide
Beyond the preview
Go deeper on Tumor-associated antigen peptide (HLA-A*02 restricted).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor-associated antigen peptide (HLA-A*02 restricted).